Elucidating the Molecular and Biochemical Basis of the Human AhR-mutation Disease
NCT03566745 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2018-06-25
Summary
In a previous study, we have identified a consanguineous family from Northern Israel with three children affected by idiopathic infantile nystagmus (IIN) and foveal hypoplasia, which follow an autosomal recessive mode of inheritance of AhR gene. in this study we will determine whether the disease phenotype is the consequence of a decrease in or absence of AHR-induced AHH activity
Conditions
- Mutation, Point
Interventions
- DIAGNOSTIC_TEST
-
Blood for protein activity
Blood for protein activity
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Principal Investigators
-
Muhammad Mahajnah, MD PhD · Hillel Yaffe mediacl center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-07-01
- Primary Completion
- 2019-06-30
- Completion
- 2019-11-30
More Related Trials
-
Intrathecal Enzyme Replacement for Hurler Syndrome
NCT00638547 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
NCT00420459 ·Status: COMPLETED ·Phase: PHASE2
-
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients
NCT04098211 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy
NCT00973011 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I
NCT02371226 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Follow-Up of Subjects Treated With AXO-AAV-GM2 for Tay-Sachs or Sandhoff Disease
NCT06614569 ·Status: ACTIVE_NOT_RECRUITING
-
Sirolimus for Retinal Astrocytic Hamartoma
NCT04707209 ·Status: COMPLETED ·Phase: NA
-
Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome
NCT07150013 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
NCT05616793 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies
NCT02710500 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101
NCT04655911 ·Status: TERMINATED
-
Measurement of Frataxin mRNA in Biofluids
NCT06496451 ·Status: COMPLETED
-
Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial
NCT02759952 ·Status: COMPLETED
-
Long-Term Follow-up Study of Subjects With Fabry Disease Who Received Lentiviral Gene Therapy in Study AVRO-RD-01-201
NCT04999059 ·Status: TERMINATED
-
A Phase 2 Open Label Extension Study in Participants With Nonsense Mutation Aniridia
NCT04117880 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease
NCT01422187 ·Status: COMPLETED ·Phase: PHASE3
-
Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA
NCT04360265 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Neuroimaging GABA Physiology in Fragile X Syndrome
NCT04308954 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
NCT05418049 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
NCT05302271 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients
NCT00718341 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I
NCT03053089 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I
NCT00912925 ·Status: COMPLETED ·Phase: PHASE3
-
Natural History Study of ATP1A3-related Disease
NCT03857607 ·Status: UNKNOWN
-
RGX-111 Gene Therapy in Patients With MPS I
NCT03580083 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2